Back to all studies
CompletedNCT01575561

Lurasidone Adjunctive to Lithium or Divalproex for Bipolarity type I

This study is completed in the United States, in France, in Argentina, .... It is testing lurasidone Adjunctive to Lithium or Divalproex for Bipolarity type I.

BipolarityDrugOver 18 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Lurasidone Adjunctive may be useful for adults experiencing bipolarity.

What would participation involve?

Participants may receive Lurasidone Adjunctive, attend study visits with the research team. The registry lists locations in Argentina, in Bulgaria, and in Chile.

Who is it mainly for?

This study appears to be mainly for adults with bipolarity.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateJune 2012
Recruitment status
Completed
Enrollment listed in the registry
377
Sponsor
Sumitomo Pharma America, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, France, Argentina, ...
Age range
Over 18 Years
Official registry ID
NCT01575561
Official title
A Multi-center, Open Label, Flexible Dose, Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects With Bipolar I Disorder

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01575561. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Argentina · 6 sites
  • Clinica Privada de Salud Mental Santa Teresa de Avila
    Buenos Aires
    Site status: Not listed — confirm with the team
  • Novain Neurociencias Group
    Buenos Aires
    Site status: Not listed — confirm with the team
  • Instituto Nacional de Psicopatología (INAPSI)
    Buenos Aires
    Site status: Not listed — confirm with the team
  • Fundacion para el estudio y tratamiento de las enfermedades mentales (FETEM)
    Buenos Aires
    Site status: Not listed — confirm with the team
  • Instituto DAMIC SRL
    Córdoba
    Site status: Not listed — confirm with the team
  • Centro de Investigacion y Asistencia en Psiquiatria (CIAP)
    Rosario
    Site status: Not listed — confirm with the team
Bulgaria · 3 sites
  • Center for Mental Health
    Rousse
    Site status: Not listed — confirm with the team
  • Multiprofiled Hospital for Active Treatment "Alexandrovska"
    Sofia
    Site status: Not listed — confirm with the team
  • Military Medical Academy
    Sofia
    Site status: Not listed — confirm with the team
Chile · 2 sites
  • Hospital El Pino
    Santiago
    Site status: Not listed — confirm with the team
  • Clinica Pedro Montt
    Santiago
    Site status: Not listed — confirm with the team
Czechia · 8 sites
  • Saint Anne, s.r.o., Psychiatricke oddeleni
    Brno - Mesto
    Site status: Not listed — confirm with the team
  • Psychiatricka ambulance
    Havířov
    Site status: Not listed — confirm with the team
  • Psychiatricka lecebna U Honzicka
    Písek
    Site status: Not listed — confirm with the team
  • Clintrial s.r.o.
    Prague
    Site status: Not listed — confirm with the team
  • Psychiatricka ambulance
    Prague
    Site status: Not listed — confirm with the team
  • Psychiatricka ambulance
    Prague
    Site status: Not listed — confirm with the team
  • Psychiatricka ambulance Prosek
    Prague
    Site status: Not listed — confirm with the team
  • Telemens, s.r.o.
    Přerov
    Site status: Not listed — confirm with the team
France · 3 sites
  • CHS La Chartreuse - Pôle 6
    Dijon
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Spécialisé du Jura - Centre Médico Psychiatrique
    Dole
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Régional Universitaire
    Nîmes
    Site status: Not listed — confirm with the team
Hungary · 4 sites
  • Kutvolgyi Klinikai Tomb SOTE IIIsz Belgyogyaszati Klinika
    Budapest
    Site status: Not listed — confirm with the team
  • Nyiro Gyula Korhaz, I. Pszichiatria
    Budapest
    Site status: Not listed — confirm with the team
  • Nyiro Gyula Korhaz, II. Pszichiatria
    Budapest
    Site status: Not listed — confirm with the team
  • Nyiro Gyula Korhaz
    Budapest
    Site status: Not listed — confirm with the team
Japan · 5 sites
  • Goryokai Medical Corporation
    Sapporo, Hokkaido
    Site status: Not listed — confirm with the team
  • Asakayama General Hospital
    Sakai, Osaka
    Site status: Not listed — confirm with the team
  • Yuge Hospital
    Kumamoto
    Site status: Not listed — confirm with the team
  • Nishigahara Hospital
    Tokyo
    Site status: Not listed — confirm with the team
  • Kawada Hospital
    Toyama
    Site status: Not listed — confirm with the team
Poland · 3 sites
  • NZOZ Syntonia
    Gdynia
    Site status: Not listed — confirm with the team
  • NZOZ BioMed
    Kielce
    Site status: Not listed — confirm with the team
  • NZOZ Prywatna Klinika Psychiatryczna Inventiva
    Tuszyn
    Site status: Not listed — confirm with the team
Russia · 6 sites
  • State Healthcare and Forensic Psychiatric Expertise Institution
    Izhevsk
    Site status: Not listed — confirm with the team
  • Saint Petersburg State Healthcare Institution "City psycho-neurology Dispanser #7"
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • St Petersburg State Government Healthcare Institution
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • St. Petersburg State Healthcare Institution "City Clinical Hospital #4"
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Mental Health Research Institute of Siberian Branch of RAMS
    Tomsk
    Site status: Not listed — confirm with the team
  • Nizhny Novgorod Regional State Institution of Healthcare
    Veliky Novgorod
    Site status: Not listed — confirm with the team
Serbia · 4 sites
  • Clinical Hospital Centre Dragisa Misovic
    Belgrade
    Site status: Not listed — confirm with the team
  • Clinical Centre Kragujevac, Psychiatric Hospital
    Kragujevac
    Site status: Not listed — confirm with the team
  • Clinic for Mental Health Protection, Clinical Centre Nis
    Niš
    Site status: Not listed — confirm with the team
  • Specialized Hospital for Psychiatric Diseased "Sveti Vracevi"
    Novi Kneževac
    Site status: Not listed — confirm with the team
Slovakia · 2 sites
  • Psychiatricke oddelenie, Vseobecna nemocnica Rimavska Sobota NaP n.o.
    Rimavská Sobota
    Site status: Not listed — confirm with the team
  • Psychiatricka ambulancia
    Zlaté Moravce
    Site status: Not listed — confirm with the team
United States · 25 sites
  • Harmonex Neuroscience Research
    Dothan, Alabama
    Site status: Not listed — confirm with the team
  • Behavioral Research Specialists, LLC
    Glendale, California
    Site status: Not listed — confirm with the team
  • AXIS Clinical Trials
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Excell Research, Inc
    Oceanside, California
    Site status: Not listed — confirm with the team
  • Stanford University School of Medicine Research Program VA Palo Alto Health Care System
    Palo Alto, California
    Site status: Not listed — confirm with the team
  • SF-Care, Inc.
    San Francisco, California
    Site status: Not listed — confirm with the team
  • Neuropsychiatric Research Center of Orange County
    Santa Ana, California
    Site status: Not listed — confirm with the team
  • Stanford University School of Medicine
    Stanford, California
    Site status: Not listed — confirm with the team
  • Florida Clinical Research LLC
    Bradenton, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions Inc.
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Galiz Research
    Miami Springs, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Clinco
    Terre Haute, Indiana
    Site status: Not listed — confirm with the team
  • Activ Med Practices & Research
    Haverhill, Massachusetts
    Site status: Not listed — confirm with the team
  • Psych Care Consultants Research
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Finger Lakes Clinical Research
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Charak Clincial Research Center
    Garlield Heights, Ohio
    Site status: Not listed — confirm with the team
  • Cutting Edge Research Group
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Suburban Research Associates
    Media, Pennsylvania
    Site status: Not listed — confirm with the team
  • Lincoln Research
    Lincoln, Rhode Island
    Site status: Not listed — confirm with the team
  • Carolina Clinical Trials
    Charleston, South Carolina
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions Inc.
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Psychoneuroendocrinology Research Group, Dept of Psychiatry, UT Southwestern Medical Center
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • R/D Clinical Research, Inc.
    Lake Jackson, Texas
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Lurasidone. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with bipolarity; age range: Over 18 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Sumitomo Pharma America, Inc., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me